eBook TNF-alpha Inhibitors (Milestones in Drug Therapy) download
by Jeffrey M. Weinberg,Robin Buchholz
Author: Jeffrey M. Weinberg,Robin Buchholz
Publisher: Birkhäuser; 2006 edition (June 30, 2006)
ePub: 1920 kb
Fb2: 1653 kb
Other formats: lit mbr rtf azw
Milestones in Drug Therapy. TNF-alpha Inhibitors.
Milestones in Drug Therapy. Over the last decade, the advent of biologic agents has greatly revolutionized therapeutic medicine in the management of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn’s disease, and psoriasis.
Tnf Alpha Inhibitors book. Goodreads helps you keep track of books you want to read. Start by marking Tnf Alpha Inhibitors (Milestones In Drug Therapy) as Want to Read: Want to Read savin. ant to Read.
Are you sure you want to remove TNF-alpha Inhibitors (Milestones in Drug Therapy) from your list? . Published June 30, 2006 by Birkhäuser Basel. There's no description for this book yet.
Are you sure you want to remove TNF-alpha Inhibitors (Milestones in Drug Therapy) from your list? TNF-alpha Inhibitors (Milestones in Drug Therapy).
from book Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD (p. 9-65). Milestones in Drug Therapy. Interorgan variation in tissue distribution of weakly basic drugs such as quinidine, propranolol, and imipramine was investigated as a function of binding to phosphatidylserine (PhS) in tissues.
Jeffrey M. Weinberg, Clement J Bottino, James Lindholm, Robin Buchholz. Journal of drugs in dermatology : JDD. 2005.
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.
Jeffrey M Weinberg Clement J Bottino James Lindholm Robin Buchholz.
Are you Jeffrey M Weinberg? Register this Author. Register with ORCID iD. PUBLICATIONS 100. Jeffrey M Weinberg. About publications (100) network. Authors: Jeffrey M Weinberg Clement J Bottino James Lindholm Robin Buchholz. J Drugs Dermatol 2005 Sep-Oct;4(5):544-55. Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA.
TNF-alfa (alpha) inhibitors (TNF-alpha) are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by white blood cells that is involved in early inflammatory events. TNF-alfa inhibitors treat a wide range of inflammatory conditions such as rheumatoid arthritis (RA), psoriatic arthritis, juvenile arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, and psoriasis.
Автор: Weinberg Jeffrey . Buchholz Robin Название: TNF-alpha Inhibitors .
TNF-alpha is known to play a crucial role in the pathogenesis of many chronic inflammatory diseases. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases.
This volume provides a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-alpha inhibitors. It is the first volume that summarizes this material for all available TNF-alpha inhibitors. Elevated levels of TNF-alpha have been demonstrated in Crohn's disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, suggesting a role for TNF-alpha in their pathogenesis. The most recent preclinical and clinical data is presented in this book.